Basilea to Present Anti-Infective Clinical Data at IDWeek 2026
Question
Basilea to Present Anti-Infective Clinical Data at IDWeek 2026
Direct answer
Basilea Pharmaceutica is set to present updated clinical data across its commercial and pipeline anti-infective franchise at the IDWeek 2026 conference in Washington D.C., running October 21 through October 24. The disclosures encompass novel pediatric data from the Expanded Access Program for antifungal candidate fosmanogepix, along with clinical analyses supporting established commercial treatments isavuconazole (Cresemba) and ceftobiprole (Zevtera). The presentations will be monitored for regulatory expansion pathways and global licensing milestones.
- Original publisher
- Market Ontology
- Evidence through
- 2026-10-20
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Basilea to Present Anti-Infective Clinical Data at IDWeek 2026”, revision 1, evidence through 2026-10-20. https://marketontology.com/market-events/2026-10-20/basilea-to-present-anti-infective-clinical-data-at-idweek-2026-955317
How this development reaches the affected companies
| Asset | Exposure and channel | Direction | Evidence |
|---|---|---|---|
| ALPMY | pipeline derisking and label expansion for commercial hospital anti-infectives | Up1-5d | Basilea presenting fosmanogepix, isavuconazole, and ceftobiprole data at IDWeek 2026. |
Does this development affect your holdings?
Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
What happened next
Price follow-up pending — no stored daily closes for these assets yet.
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.